Ashish Life Sciences fetches about $6.3 mln Series A

India-based Ashish Life Science, a generic veterinary pharmaceuticals company, has raised INR 45 crores (about $6.3 million) in Series A funding. Eight Roads Ventures India led the round with participation from Anterra Capital.